Open AccessEvaluation of Docetaxel vs. Tamoxifen in Combined Therapies Based on Overall Survival Rate (OSR) Endpoint among Female Breast Cancer Patients
Author(s) -
Oluwafemi Olawuyi,
Melanie M. Tidman
Publication year - 2017
Publication title -
advances in cancer prevention
Language(s) - English
Resource type - Journals
ISSN - 2472-0429
DOI - 10.4172/2472-0429.1000122
Subject(s) - docetaxel , medicine , tamoxifen , capecitabine , oncology , breast cancer , clinical trial , randomized controlled trial , cancer , colorectal cancer